European commission grants "orphan" status for new acute myeloid leukaemia treatment
...ralised" procedure for assessment of the marketing authorisation application. Orphan medicinal products are intend... reductions for all types of centralised marketing authorisation evaluation activities.If approved by the EMEA, Mylotarg would be the first product available in Euro...Xeloda approved for breast cancer treatment in Europe
...that the European Commission has granted marketing authorisation for Roches anti-cancer tablet Xeloda (capecitabine... breast cancer. Last year Roche received marketing authorisation for Xeloda in the treatment of metastatic colorectal cancer in most countries worldwide, including t...Roche files marketing application for Avastin with European health authorities
...delighted to announce the submission for marketing authorisation of Avastin in the European Union," said William M. Burns, Head of Roche Pharmaceuticals Division. "Roche is dedicated to the development of safe and efficacious treatments for many types of cancers, and we will work closely with regulatory authoriti...VELCADE (Bortezomib) receives European marketing authorisation
... 13 May 2003. "We are delighted that marketing authorisation for VELCADE has been granted, as it is the first major advance for patients with multiple myeloma in more than a decade, and marks the company's commitment to Oncology." said Ken Watters, European Medical Director, Ortho Biotech. "The approval of VEL...